CASOLARI, Paolo
 Distribuzione geografica
Continente #
NA - Nord America 7.114
AS - Asia 3.761
EU - Europa 2.508
SA - Sud America 551
AF - Africa 77
OC - Oceania 23
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.039
Nazione #
US - Stati Uniti d'America 6.968
SG - Singapore 1.425
CN - Cina 931
IT - Italia 772
DE - Germania 460
VN - Vietnam 436
BR - Brasile 426
UA - Ucraina 346
HK - Hong Kong 287
FI - Finlandia 238
TR - Turchia 216
GB - Regno Unito 201
FR - Francia 131
BD - Bangladesh 126
SE - Svezia 98
RU - Federazione Russa 85
JP - Giappone 83
CA - Canada 67
IN - India 67
MX - Messico 63
ID - Indonesia 44
AR - Argentina 43
NL - Olanda 41
PL - Polonia 36
ZA - Sudafrica 30
IQ - Iraq 23
EC - Ecuador 21
AU - Australia 18
BE - Belgio 17
PK - Pakistan 17
ES - Italia 15
MA - Marocco 14
VE - Venezuela 14
LT - Lituania 13
PH - Filippine 13
CO - Colombia 12
UZ - Uzbekistan 12
PY - Paraguay 11
AE - Emirati Arabi Uniti 10
MY - Malesia 10
AT - Austria 8
TN - Tunisia 8
TW - Taiwan 8
CL - Cile 7
NP - Nepal 7
PE - Perù 7
UY - Uruguay 7
AL - Albania 6
KE - Kenya 6
SA - Arabia Saudita 6
AZ - Azerbaigian 5
EG - Egitto 5
HR - Croazia 5
BG - Bulgaria 4
CZ - Repubblica Ceca 4
DZ - Algeria 4
IE - Irlanda 4
JO - Giordania 4
NZ - Nuova Zelanda 4
RO - Romania 4
TH - Thailandia 4
BA - Bosnia-Erzegovina 3
CH - Svizzera 3
HU - Ungheria 3
KR - Corea 3
KZ - Kazakistan 3
LB - Libano 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CG - Congo 2
CR - Costa Rica 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
IL - Israele 2
IR - Iran 2
JM - Giamaica 2
LK - Sri Lanka 2
NI - Nicaragua 2
NO - Norvegia 2
PT - Portogallo 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
UG - Uganda 2
AM - Armenia 1
BB - Barbados 1
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CM - Camerun 1
ET - Etiopia 1
GF - Guiana Francese 1
GP - Guadalupe 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
LI - Liechtenstein 1
Totale 14.027
Città #
Singapore 869
Ashburn 734
Fairfield 641
Woodbridge 556
San Jose 468
Houston 393
Jacksonville 382
Santa Clara 332
Hong Kong 283
Ann Arbor 281
Beijing 279
Chandler 279
Munich 256
Seattle 241
Wilmington 220
Cambridge 205
Washington 201
Ho Chi Minh City 141
Izmir 138
Los Angeles 127
Helsinki 125
Nanjing 123
New York 113
Milan 110
Hanoi 100
Dallas 95
Princeton 86
Tokyo 79
Lauterbourg 73
Ferrara 72
Council Bluffs 71
Boardman 57
Rome 57
Chicago 44
San Diego 43
Mexico City 38
Shanghai 37
Dearborn 35
Warsaw 33
Orem 32
Addison 31
São Paulo 31
Buffalo 30
Jakarta 30
Toronto 30
Nanchang 29
Turku 28
Shenyang 27
Hebei 26
Tianjin 25
Brooklyn 22
Da Nang 21
Hefei 20
Jiaxing 20
London 20
Frankfurt am Main 19
Cardiff 18
Changsha 18
Haiphong 18
Chennai 17
Montreal 17
Naples 17
Atlanta 16
Bologna 16
Denver 16
Florence 16
Guangzhou 16
Moscow 16
Mountain View 16
San Francisco 16
Hải Dương 15
Kunming 15
Brussels 14
Johannesburg 14
Turin 14
Bremen 13
Parma 13
Boston 12
Manchester 12
Redwood City 12
Auburn Hills 11
Jinan 11
Rio de Janeiro 11
The Dalles 11
Belo Horizonte 10
Blackpool 10
Campinas 10
Jyväskylä 10
Philadelphia 10
Taizhou 10
Verona 10
Amsterdam 9
Baghdad 9
Curitiba 9
Dong Ket 9
Falls Church 9
Norwalk 9
Padua 9
Salt Lake City 9
Ningbo 8
Totale 9.419
Nome #
Asthma death. Part 1: Clinical phenotypes, epidemiology and risk factors 516
Role of Stem Cells in the Pathogenesis of COPD and Pulmonary Emphysema 345
Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations 341
Polmonite da ipersensibilità da antigeni aviari in un italiano adulto 325
Targeting Th2 cells in asthmatic airways 303
Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD 284
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 259
ALTERATION OF ADENOSINE RECEPTORS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE 220
Alteration of adenosine receptore in patients with chronic obstructive pulmonary disease 220
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary disease 216
Reducing agents decrease the oxidative burst and improve clinical outcomes in COPD patients: A randomised controlled trial on the effects of sulphurous thermal water inhalation 216
Differential expression of RNA-binding proteins in bronchial epithelium of stable COPD patients 215
Activation of NF-kappaB transcription factor in asthma death 214
Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up 212
Airway inflammatory profile is correlated with symptoms in stable COPD: A longitudinal proof-of-concept cohort study 211
Cellule staminali e patologia polmonare dell’adulto 207
T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients 206
Immune Response to Mycobacterium tuberculosis Infection in the Parietal Pleura of Patients with Tuberculous Pleurisy 204
Phospho-p38 MAPK expression in COPD patients and asthmatics and in challenged bronchial epithelium 203
Increased expression of aquaporin 5 in bronchial glands of smokers with or without COPD 191
Circulating Endothelial Stem Cells in Age-Matched Smokers with or without Mild-to-Moderate Pulmonary Emphysema 183
Role of stem cells in the pathogenesis of chronic obstructive pulmonary disease and of pulmonary emphysema 182
Unbalanced oxidant-induced DNA damage and repair in COPD: A link towards lung cancer 179
MUC5AC expression is increased in bronchial submucosal glands of stable COPD patients 176
Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus 175
Mechanisms involved in lung cancer development in COPD 169
Mucin expression in peripheral airways of patients with chronic obstructive pulmonary disease 169
Morte per asma. Parte II: patogenesi, quadro anatomo-patologico, diagnosi differenziale e prevenzione. 167
Ruolo dello stress ossidativo nella patogenesi delle broncopneumopatie croniche ostruttive in fase stabile. 167
Mechanisms of corticosteroid resistance in severe asthma and chronic obstructive pulmonary disease (COPD) 165
Expression and activation of the major subunit of NF-kB, protein p65, in COPD bronchial glands 165
Lower airways inflammation in patients with ARDS measured using endotracheal aspirates: a pilot study. 165
Recent thymic emigrants do not account for the increased number of T-cells seen in the lungs of stable chronic obstructive pulmonary disease 164
Rhinovirus-induced CCL17 and CCL22 in Asthma Exacerbations and Differential Regulation by STAT6 164
Pathophysiology of viral-induced exacerbations of COPD 163
SARS-CoV-2 infection as a model to study the effect of cinnamaldehyde as adjuvant therapy for viral pneumonia 162
Cytoplasmic expression of p21 CIPI/WAF1 is increased in endoalveolar macrophages of smokers. 160
Expression of human Interferon Regulatory Factor 3 (IRF-3) in alveolar macrophages relates to clinical and functional traits in COPD 155
Circulating endothelial stem cells in age-matched smokers with or without mild-to-moderate pulmonary emphysema 152
COPD immunopathology 151
COPD pathology in the small airways 150
New drugs targeting Th2 lymphocytes in asthma 149
Increased deposition of activated complement in peripheral lung vessels of smokers 144
Expression of the phosphorylated myristoylated alanine-rich C kinase substrate (MARCKS) in COPD bronchial glands 143
Alteration of adenosine receptors in patients with chronic obstructive pulmonary disease 143
SAA and lipid metabolism in IPF 136
Ruolo dei marcatori non invasivi di stress ossidativo nelle broncopneumopatie croniche ostruttive 131
TGF-β Signaling Pathways in Different Compartments of the Lower Airways of Patients With Stable COPD 126
Glucocorticoids impair type I IFN signalling and enhance rhinovirus replication 122
null 121
IL-22 and its receptors are increased in human and experimental COPD and contribute to pathogenesis 121
Mucin expression in the bronchiolar epithelium of patients with chronic obstructive pulmonary disease. 120
MUC5AC and MUC5B expression in central airways from non-smokers, smokers with normal lung function and GOLD stage 1 and 2 COPD patients 119
Trattamento personalizzato dei pazienti con BPCO in fase stabile 119
Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients 118
null 118
Fluticasone furoate and vilanterol for the treatment of chronic obstructive pulmonary disease 117
Chemokines and chemokine receptors blockers as new drugs for the treatment of chronic obstructive pulmonary disease 115
null 114
Oxidative/nitrosative stress selectively altered A2B adenosine receptors in chronic obstructive pulmonary disease. 109
Scavenger Receptor B1 involvement in COPD pathogenesis 104
Xanthine oxidase inhibitors reduce rhinovirus induced IL-8 and gro- production in bronchial epithelial cells. 104
Expression of transforming growth factors beta (1, 2, 3) and connective tissue growth factor in the peripheral lung from GOLD stage 1-2 COPD patients and smokers with normal lung function 104
Inhibition of PI-3Kdelta restores glucocorticoid function in smoking-induced airway inflammation in mice 103
Expression of adenosine receptors in the peripheral lung from COPD patients. 103
Xanthine-Oxidase System Activation Is Required in Rhinovirus Induced Oxidant Production in Respiratory Epithelial Cells 103
null 102
Expression of Heat Shock Proteins 70 and 90 in COPD Peripheral Lung 101
Rhinovirus infection causes steroid resistance in airway epithelium through nuclear factor κb and c-Jun N-terminal kinase activation 101
Differential responses of pulmonary vascular cells from PAH patients and controls to TNFα and the effect of the BET inhibitor JQ1 99
Definition and aetiology of infective exacerbations of COPD 98
FN3K expression in COPD: a potential comorbidity factor for cardiovascular disease 98
Innate immunity but not NLRP3 inflammasome activation correlates with severity of stable COPD. 97
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: fisiologia. 97
null 92
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. 92
Ruolo dei fattori di crescita dell’endotelio vascolare e dei loro recettori nella patogenesi delle malattie polmonari dell’adulto: patologia. 91
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive.Basi fisiologiche. II parte. 91
Fattori di trascrizione: la nuova frontiera della ricerca nell’asma bronchiale e nelle broncopneumopatie croniche ostruttive. Basi fisiologiche. I parte. 91
null 91
null 91
Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations 91
null 90
Heat shock proteins 70 and 90 expression in peripheral lung of COPD patients 89
null 88
null 88
null 81
null 81
Ruolo delle infezioni virali nelle riacutizzazioni asmatiche. 77
Nuclear factor κ-B is activated in the pulmonary vessels of patients with end-stage idiopathic pulmonary arterial hypertension. 70
null 66
Nasal inflammation and its response to local glucocorticoid regular treatment in patients with persistent non-allergic rhinitis: a pilot study 61
Glycogen synthase kinase-3β modulation of glucocorticoid responsiveness in COPD 55
null 51
Oxidative Stress-induced Antibodies to Carbonyl-modified Protein Correlate with Severity of Chronic Obstructive Pulmonary Disease 51
Role of transcription factors in the pathogenesis of asthma and COPD 50
Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension. 42
STAT3 and STAT6 activation in lung tissues correlates with inflammatory and clinical traits in COPD 39
Totale 14.199
Categoria #
all - tutte 61.800
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.710
Totale 64.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022730 26 71 70 54 24 36 26 49 22 58 85 209
2022/2023731 91 21 25 92 120 107 32 61 95 3 54 30
2023/2024353 39 45 14 6 28 55 10 17 6 10 12 111
2024/20252.025 42 52 141 49 234 223 138 154 368 214 224 186
2025/20265.423 447 238 447 616 835 291 611 370 513 589 257 209
2026/2027156 156 0 0 0 0 0 0 0 0 0 0 0
Totale 14.199